ReviewTranslational andrology and urology2025
Advances in erectile dysfunction treatment research: a narrative review.
Review in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Unconsummated marriage: etiology and treatment of erectile dysfunction in newlywed men-a narrative review with a focus on China.Translational andrology and urology · 2026Review
- Wearable technology-derived digital biomarkers for non-invasive assessment of erectile dysfunction: a cross-sectional pilot study.International urology and nephrology · 2026Article
- Erectile Dysfunction: A Comprehensive Review of Pathophysiology, Diagnosis and Contemporary Management.Medicina (Kaunas, Lithuania) · 2026Review
- From symptomatic relief to restorative medicine: a comprehensive review of diabetic erectile dysfunction.Translational andrology and urology · 2026Review
- Improving Sexual Dysfunction with Cinnamon Leaf Extract and Nanoemulsion by Using a Rat Model.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Color Doppler ultrasound results of erectile dysfunction patients after an intracavernosal injection of prostaglandin E1: an analysis of 9,109 cases.Translational andrology and urology · 2026Article
- Clinical performance of a novel brief erectile dysfunction scale and comparison with the international index of erectile function-5.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Erectile dysfunction (ED) is one of the common diseases in middle-aged and older men, and its etiology mainly includes vascular diseases, neurological diseases, metabolic disorders, and psychological factors. This review takes the physiological mechanisms of penile erection as a starting point and provides an in-depth look at the major current treatments, which include phosphodiesterase type 5 (PDE5) inhibitors, gene therapy techniques, low-intensity extracorporeal shock wave therapy (Li-ESWT), low-intensity pulsed ultrasound therapy (LIPUS), and psychological treatments. The review further provides a critical analysis and summary of the advantages and limitations associated with each treatment approach. Finally, the article discusses the future directions of ED treatment, emphasizing the importance of integrating personalized and precision medicine principles into treatment planning to identify the most appropriate therapeutic strategy for each patient. Methods: We conducted literature searches on academic platforms such as PubMed, Google Scholar, and Web of Science using the terms "erectile dysfunction", "stem cells", "low-intensity extracorporeal shock wave", "low-intensity pulsed ultrasound", "PDE5 inhibitors", "gene therapy", "penile prosthesis implantation", and "psychosexual therapy" collecting literature published from January 1990 to October 2024. Key Content and Findings: The incidence of ED is showing a trend of becoming more widespread and affecting younger people. We have identified the main risk factors that cause ED, which include psychological disorders, hypertension, cardiovascular diseases (CVDs), and unhealthy lifestyles. On this basis, this study comprehensively reviews the latest research progress of traditional treatment methods and emerging treatment approaches, and analyzes their respective advantages and limitations. Conclusions: As ED treatment technologies continue to advance, the erectile function of numerous patients has seen significant improvement. Looking at the future development trend, combined treatment is expected to become the mainstream strategy for treating ED, and the treatment methods for this condition will gradually move towards personalization and precision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.